US-based personalised medicine technology company Assurex Health has raised $30m from investors including healthcare provider Mayo Clinic and Cincinnati Children’s Hospital Medical Center.
American Financial Group, Cross Creek Advisors, Sequoia Capital, Claremont Creek Ventures, CincyTech, Allos Ventures and Danmar Capital also participated in the round.
Assurex’s lead product is GeneSight, a test that helps healthcare providers prescribe treatments for mental health disorders based on a patient’s unique genetic makeup.
Apart from American Financial Group and Cross Creek, all of the investors previously contributed to a $7m equity round in May this year raised alongside $25m of debt from Silicon Valley Bank.
Assurex has now secured approximately $68.5m in total equity funding.
Warren Hogarth, partner at Sequoia Capital, said: “For patients and families facing the challenges of mental health and pain management, Assurex Health offers a proven path to better outcomes. This investment round will allow the company to reach more clinicians and patients while expanding its scientific and clinical foundations.”